Founders Capital Management (Texas)’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-71
| Closed | -$171 | – | 435 |
|
|
2023
Q2 | $171 | Hold |
71
| – | – | ﹤0.01% | 391 |
|
|
2023
Q1 | $1K | Hold |
71
| – | – | ﹤0.01% | 383 |
|
|
2022
Q4 | $1K | Sell |
71
-186
| -72% | -$2.62K | ﹤0.01% | 373 |
|
|
2022
Q3 | $4K | Hold |
257
| – | – | ﹤0.01% | 352 |
|
|
2022
Q2 | $9K | Hold |
257
| – | – | 0.01% | 332 |
|
|
2022
Q1 | $11K | Hold |
257
| – | – | 0.01% | 267 |
|
|
2021
Q4 | $11K | Hold |
257
| – | – | 0.01% | 267 |
|
|
2021
Q3 | $17K | Hold |
257
| – | – | 0.01% | 233 |
|
|
2021
Q2 | $20K | Buy |
257
+143
| +125% | +$11.1K | 0.01% | 204 |
|
|
2021
Q1 | $8K | Hold |
114
| – | – | 0.01% | 261 |
|
|
2020
Q4 | $4K | Buy |
+114
| New | +$4K | ﹤0.01% | 282 |
|
|
2020
Q1 | $3K | Hold |
114
| – | – | ﹤0.01% | 292 |
|
|
2019
Q4 | $6K | Buy |
114
+57
| +100% | +$3K | ﹤0.01% | 288 |
|
|
2019
Q3 | $3K | Buy |
57
+28
| +97% | +$1.47K | ﹤0.01% | 309 |
|
|
2019
Q2 | $3K | Hold |
29
| – | – | ﹤0.01% | 318 |
|
|
2019
Q1 | $4K | Hold |
29
| – | – | ﹤0.01% | 310 |
|
|
2018
Q4 | $5K | Hold |
29
| – | – | 0.01% | 293 |
|
|
2018
Q3 | $7K | Buy |
+29
| New | +$7K | 0.01% | 267 |
|